Lessons from developing regional oncology pathways to improve cancer careA study, performed by a consortium of collaborators, including Cancer Center Amsterdam, evaluated the development of regional oncology care pathways within the OncoNoVo+ network, involving 13 hospitals and 216 professionals across multiple specialties.
AI accelerates leukemia cell detectionFor many patients with acute myeloid leukemia (AML), the disease unfortunately returns after initially successful treatment. Amsterdam UMC has been a leader for 25 years in developing sensitive methods to detect residual leukemia cells. With artificial intelligence (AI), this can now be done just as accurately, yet much faster.